Back to results
CompletedPhase 3

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Alabaster, Alabama, United States

+261 additional locations

View on ClinicalTrials.gov
Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — TrialFind